Is Colgate-Palmolive Company (CL) A Good Stock To Buy Now?
π Colgate-Palmolive (CL) shares traded at $92.07 with a trailing P/E of 35.69 and forward P/E of 23.87 as of June 26, 2026.
π The company operates in over 200 countries with a diversified revenue base led by oral, personal, and home care segments contributing 77% of sales.
π¦· Colgate maintains a dominant market position with over 40% share of the global toothpaste market supported by powerful brand equity.
π Management under CEO Noel Wallace has achieved six consecutive years of organic sales growth and annual revenue exceeding $20 billion.
π° The company is a Dividend King with 63 consecutive years of dividend increases and returns over $1 billion annually via share repurchases.
πΎ Hill's Pet Nutrition segment accounts for 23% of sales and is expected to outpace traditional consumer staples due to humanization trends.
πͺ Colgate possesses a conservative balance sheet with healthy interest coverage and high returns on invested capital.
β οΈ Structural risks include competitive pressures, foreign exchange volatility, input cost inflation, and the maturity of core categories.
π CL stock has depreciated approximately 8.35% since previous bullish coverage in October 2024.
π¦ Hedge fund interest remains stable with 62 portfolios holding CL at the end of Q1 2026, unchanged from the prior quarter.
- Colgate has delivered six consecutive years of organic sales growth while maintaining annual revenue above $20 billion.
- The company holds a dominant market share of over 40% in the global toothpaste market, providing strong pricing power.
- As a Dividend King with 63 consecutive years of dividend increases, Colgate offers exceptional income stability to shareholders.
- Disciplined capital allocation is evidenced by high returns on invested capital and annual share repurchases exceeding $1 billion.
- The pet nutrition segment is positioned for superior growth compared to traditional consumer staples due to rising pet humanization trends.
- Management's 2030 strategic plan successfully integrates digital and physical retail while expanding premium offerings.
- The company faces structural risks from competitive pressures, foreign exchange volatility, and input cost inflation.
- Core business categories are maturing, which may limit high-growth opportunities in the traditional oral and home care segments.
- CL stock has depreciated by approximately 8.35% since previous bullish coverage, indicating recent market weakness.